APHA - Aphria Inc.

NYSE - NYSE Delayed Price. Currency in USD
6.29
+0.07 (+1.13%)
At close: 4:02PM EDT

6.27 -0.02 (-0.32%)
After hours: 5:45PM EDT

Stock chart is not supported by your current browser
Previous Close6.22
Open6.13
Bid6.27 x 1400
Ask6.33 x 1300
Day's Range6.00 - 6.34
52 Week Range3.75 - 16.86
Volume2,660,418
Avg. Volume3,929,089
Market Cap1.574B
Beta (3Y Monthly)3.45
PE Ratio (TTM)21.04
EPS (TTM)0.30
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Medicare-for-all could ‘dramatically’ increase access to medical cannabis
    Yahoo Finance Video14 days ago

    Medicare-for-all could ‘dramatically’ increase access to medical cannabis

    Key Democrats have been talking up Medicare-for-all in the presidential race, and Nicholas Vita, the CEO of cannabis company Columbia Care, says a move to that type of health care system could benefit medical cannabis too. He spoke to Yahoo Finance’s Brian Sozzi and Akiko Fujita.

  • Cresco Labs updates expansion plans as Illinois legalizes recreational marijuana
    Yahoo Finance Video19 days ago

    Cresco Labs updates expansion plans as Illinois legalizes recreational marijuana

    Illinois became the 11th state to legalize recreational marijuana use, and the first to do so by way of the legislative process as opposed to ballot initiatives. Cresco Labs has announced its approved to open 5 additional dispensaries on the news. Yahoo Finance's Zack Guzman and Sibile Marcellus are joined by Beth Comstock, former GE Vice Chair and ‘Imagine It Forward’ author, to discuss.

  • 4 Best Marijuana ETFs for Conservative Portfolios
    InvestorPlace10 hours ago

    4 Best Marijuana ETFs for Conservative Portfolios

    [Editor's note: "4 Best Marijuana ETFs for Conservative Portfolios" was previously published in May 2019. It has since been updated to include the most relevant information available.]Investors are clamoring for ways to get in on a popular, but risky, marijuana-investing craze. Despite the reality that cannabis is illegal under federal law, many states have legalized the substance and plenty of marijuana ETFs have cropped up as a result.For recreational use, Oregon, Massachusetts, California and a few more states allow marijuana use. Yet, the majority of U.S. states have medical marijuana legislation in the pipeline. Presently, with the legal disconnect between federal and state law regarding marijuana use, investing directly in U.S. marijuana ETFs and stocks is risky and replete with scams and fraud.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Dependable Dividend Stocks to Buy If you're determined to get in on the marijuana investing scene, there are several "conservative-ish" marijuana ETFs for partaking in the speculative pot party: Alternative Harvest ETF (MJ)Hot off the New York Stock Exchange, the Alternative Harvest ETF (NYSEARCA:MJ) began trading on Dec. 26, 2017.Source: Shutterstock Derived from an international real estate investment trust (REIT) fund, the marijuana ETF tracks cannabis cultivators, producers and distributors, along with cannabinoid drug makers, fertilizer producers and tobacco companies.As the first of what is sure to be many U.S. marijuana ETFs, the Alternative Harvest enjoys a first-mover advantage. American Growth Fund (AMREX)It's risky to call American Growth Funds Series Two Class E (MUTF:AMREX) a conservative marijuana pick., as the fund has racked up significant losses in the pastSource: Shutterstock Yet, if you're a contrarian seeking a fund with access to the cannabis industry through marijuana ETFs you might consider AMREX.AMREX's top holdings include some well-known names and other niche pot players including GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Scotts Miracle-Gro Co (NYSE:SMG), Abbott Laboratories (NYSE:ABT), Cara Therapeutics Inc (NASDAQ:CARA), Cannabis Sativa Inc (OTCMKTS:CBDS) and more. * 7 Dependable Dividend Stocks to Buy The fund is small and hasn't gained serious investor traction, but it might be a good diversifier against the movements of the S&P 500. Cronos Group Inc. (CRON)Go north for another fund tapping into marijuana ETFs. Cronos Group (NASDAQ:CRON), formerly known as PharmaCan Capital Corp, and formerly trading on the OTC market under "PRMCF," is an investment firm focused on investing in the medical marijuana industry.Source: Shutterstock Cronos' investments abide by Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Founded in 2013 in Toronto, the fund targets Canadian firms and makes minority investments in cannabis-related firms. Create Your Own Pot Mutual FundDiversification is key when investing in a speculative sphere like marijuana ETFs. You might want to dip your toes in the above marijuana ETFs and add in some popular cannabis-related stocks to round out your pot portfolio.Source: Shutterstock M1 Finance and Motif both allow you to create your own mutual fund, for extremely low fees. You can choose the investments, purchase your preferred amount and voila, you have your own marijuana ETF, comprised of both funds and individual stocks!In addition to the funds profiled above, consider adding several pure marijuana industry stocks and pot-related holdings. Top marijuana stocks include Canopy Growth, Aphria Inc (NYSE:APHA) and GW Pharmaceuticals. Peripherally related pot stocks include Scotts Miracle-Gro or Constellation Brands, Inc. (NYSE:STZ). * 7 Dependable Dividend Stocks to Buy Investing in marijuana is risky. With the disconnect between state and federal marijuana laws, putting your money in this sector sets you up for a roller coaster ride. Tread cautiously into the pot investing fields.Barbara A. Friedberg, MBA, MS is a veteran portfolio manager, expert investor, and former university finance instructor. She is editor/author of Personal Finance; An Encyclopedia of Modern Money Management and two additional money books. She is CEO of Robo-Advisor Pros.com, a robo-advisor review and information website. Additionally, Friedberg is publisher of the well-regarded investment website Barbara Friedberg Personal Finance.com. Follow her on twitter @barbfriedberg and @roboadvisorpros. As of this writing, she does not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dependable Dividend Stocks to Buy * 10 Stocks Driving the Market to All-Time Highs (And Why) * 7 Short Squeeze Stocks With Big Upside Potential The post 4 Best Marijuana ETFs for Conservative Portfolios appeared first on InvestorPlace.

  • The CannTrust Scandal: 5 Thoughts From a Shareholder
    Motley Fool3 days ago

    The CannTrust Scandal: 5 Thoughts From a Shareholder

    CannTrust drops a bombshell announcement on investors. Here's what you should know.

  • 7 Marijuana Stocks With Critical Levels to Watch
    InvestorPlace4 days ago

    7 Marijuana Stocks With Critical Levels to Watch

    [Editor's note: This story will be updated each week with new stocks and analysis. Please check back often for Mark's latest take on marijuana stocks.]Technical analysis is very misunderstood. This does not surprise me because most of the technical analysts that I see just don't get it. They mindlessly look at charts and try to identify patterns without understanding what they are supposed to mean. Even worse, some analysts promote dubious methods like harmonic charts and Elliot waves (these techniques are like Sasquatch and UFOs. They may be fun to talk about but they are not real. Institutional traders do not use them).In financial markets, prices are always doing one of three things. They are either going up, going down or staying the same.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIn addition, in financial markets certain price levels are more important than others with regards to the amount of supply and demand that exists at them. If understood and utilized correctly, technical analysis should be an illustration of these supply-and-demand dynamics.Having a knowledge of these dynamics can help you make money. Short-term traders need to know which levels are important in order to be successful. Long-term holders can benefit by having a better understanding of where to place their buy and sell orders.For example, say you buy a stock at $10 and plan on selling it when it gets to $20. You should look at the chart, because if there is significant resistance at $19, the stock may not get to $20. It may rally and hit the resistance at $19, and then reverse its trend and go back to $10. If you had a limit order at $20, it would not have been filled and you would have missed making a significant profit. * 10 Stocks to Sell for an Economic Slowdown Let's take a look at seven of the most popular marijuana stocks and some of the technical levels in each. A lesson can be learned from each of them. Marijuana Stocks: Cronos (CRON)Cronos (NASDAQ:CRON) grows and sells marijuana. It has been consolidating over the past month.You don't need to be a Market Guru to see that the $14 level is important. It was support in May and June. This is because in September and December it was resistance. How does this happen? How does resistance become support? Consider the following.Those who sold it at $14 were feeling pretty good after it went lower. The short-sellers are making money and the regular sellers are happy because they made the correct decision when they decided to sell.Then in January the stock rallied and went through $14 to higher levels. Now the short-sellers are losing money and they tell themselves that they will buy it if it gets back to $14 so they can break even. The regular sellers tell themselves that they made a mistake selling it. If it comes back to $14, they will buy it back. Those who bought it at $14 wish they bought more and tell themselves they will if it gets back to $14.Add to that professional traders who wish to profit off of a clear level, and we now have four groups of interested buyers at $14. This is how support forms. Canopy Growth (CGC)Canopy Growth (NYSE:CGC) grows and sells marijuana.You can see that the $40 level is important for CGC. It was support in April and early June. It is testing that level again now, and it appears to be breaking. If it does break, the stock could drop to $30 pretty quickly. This is because in January it gapped up from $30 to $40. Gaps tend to refill.When a stock gaps, up it doesn't spend much time trading at the levels that it gapped through. Because of this, meaningful support would not develop at these levels. * 7 Retail Stocks to Buy for the Second Half of 2019 As we have seen, support forms because those who sold at a particular level want to buy it back after it goes higher while those who bought it wish they bought more.So ultimately, if CGC stock falls, it could fall a ways. Aphria (APHA)Aphria (NYSE:APHA) grows and sells marijuana.APHA has been trending lower over the past two weeks. Longer-term, there is support around the $6.25 level and resistance around the $7.30 level.Few think about it, but a clearly defined support or resistance level is an amazing thing. How is it that at different points in time, a stock can have the exact same valuation? Interest rates are different, the economy is different, and different news has come out.No academic or efficient market believer could ever explain why certain levels are more important than others. According to them, clear levels shouldn't exist. But as we can see here, they most certainly do.If APHA continues to trade lower, it will probably find support again around $6.25. If you like the company, that would be a logical place to buy it. If it rallies, I would look for resistance around the $7.30 level again. Tilray (TLRY)Tilray (NASDAQ:TLRY) grows and sells marijuana. And TLRY stock illustrates the concept of trends and trendlines quite nicely. These are not as mysterious as some seem to think. Drawing trendlines is an art and not a science, but with some experience and practice, it can help your investments.When prices are moving up in a market, the forces of demand are in control. When prices are falling, the forces of supply are in control. When markets are consolidating or trading sideways, the forces of supply and demand are equal.The break of a trendline could be a signal that the leadership of the market is about to change or equalize. * 10 Best Stocks for 2019: A Volatile First Half As we can see here, the forces of supply drove TLRY lower from February through June. Since then, the forces of supply and demand have equalized. The break of the downtrend line in June was an early indication that this was going to happen. CannTrust Holdings (CTST)CannTrust Holdings (NYSE:CTST) grows and sells medical marijuana.A valuable lesson about buying a stock can be learned here. $4.80 has been clear support, and each time that CTST traded down to that level over the past year a significant rally followed.As the stock once again approached this level, some traders would want to buy it hoping that it would rally again. Most would just buy it around $4.80. But there is a better strategy, and this is illustrated here. Instead of buying it at $4.80, wait until the downtrend line is broken before entering the position.In other words, buy it on the way up. You won't get the exact low price but the risk-reward ratio is better than just guessing that the selloff is over.In this case, this strategy would have saved investors a lot of money. After cutting through $4.80, the company got dinged with a non-compliance report from Health Canada that sent shares plummeting toward $3. Anyone who bought around $4.80 likely isn't too happy with that decision right about now. Cure Pharmaceutical Holding (CURR)Cure Pharmaceutical (OTCMKTS:CURR) develops and manufactures drugs and drug delivery systems. The $4.50 level is important here. It was resistance in August and September and then again in March.Over the past few weeks, CURR stock rallied through this level, but it became overextended and overbought. As expected, it reversed and found support at the $4.50 level.This is another example of how resistance becomes support. Those who sold it say they will buy it back if it gets down to their level. Those who bought it want to buy more. * 7 A-Rated Stocks to Buy for the Rest of 2019 If you like the long-term prospects of this company, this would probably be a good time to buy it. Innovative Industrial Properties (IIPR)Innovative Industrial Properties (NYSE:IIPR) acquires industrial properties and rents space to marijuana growers. This company is a great example of an ancillary business to the cannabis industry. It has also performed exceptionally well.We can see here what technicians call a "pennant" or "flag" pattern. This type of pattern is typically a continuation pattern.In other words, it shows that the buyers that drove up the price have decided to take a break and see if the stock will come down a little allowing them to buy it at better prices. Once these buyers reenter the market, they will drive it higher again.For example, a money manager may really want to own a stock. They buy it aggressively on Monday and Tuesday and drive up the price. Then on Wednesday, they take a break and the stock price doesn't move. On Thursday and Friday they decide to finish their buying and they take the price up again. This type of activity would look like a flag on a chart.At the time of this writing, Mark Putrino did not hold any positions in the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell for an Economic Slowdown * 7 Marijuana Penny Stocks That I May Buy * 7 of The Best Schwab ETFs for Low Fees The post 7 Marijuana Stocks With Critical Levels to Watch appeared first on InvestorPlace.

  • CNW Group5 days ago

    High Tide Announces Canna Cabana Selling Cannabis at 2 More Alberta Locations

    High Tide Announces Canna Cabana Selling Cannabis at 2 More Alberta Locations

  • Forget Short-Sellers! This Is the No. 1 Enemy of Pot Stocks Right Now
    Motley Fool5 days ago

    Forget Short-Sellers! This Is the No. 1 Enemy of Pot Stocks Right Now

    The recent poor performance of marijuana stocks can be traced to one source.

  • InvestorPlace7 days ago

    Where Is Canopy Growth Stock Headed After the Shocking Removal of Its Co-CEO?

    Some of the leading companies in the cannabis space are feeling pressure to justify the huge valuations of their stocks. Just look at Canopy Growth (NYSE:CGC). Recently, the company announced that its co-CEO, Bruce Linton, would step down.On an interim basis, co-CEO Mark Zekulin will run the company until a permanent leader is found. The company is considering both internal and external candidates.In a CNBC interview following his departure,, Linton said: "I think stepping down might not be the right phrase. I was terminated."InvestorPlace - Stock Market News, Stock Advice & Trading TipsAll this comes after CGC reported disappointing fiscal fourth-quarter earnings on June 20. CGC announced adjusted EBITDA of negative $257 million for the fiscal year. But perhaps the most worrisome part of the report was that its Q4 gross recreational Canadian revenue fell to C$68.9 million from C$71.6 million during the same period a year earlier. This is an indication that there are still complications with the supply and distribution of cannabis in Canada as well as continuing black-market activities. * 5 Dividend Stocks to Buy From Across the Globe The management of Constellation Brands (NYSE:STZ), which invested a whopping $4 billion Canopy stock in November, was far from thrilled. Here's what Constellation CEO William Newlands said last week about CGC: "And while we remain happy with our investment in the cannabis space and its long-term potential, we were not pleased with Canopy's recent reported year end results."Yikes! It looks like STZ played a major role in Linton's departure.So what should investors do with CGC stock now? I don't think the owners of Canopy Growth stock should panic, since the company's long-term prospects still look promising. The following developments should be bullish for CGC stock: * CGC has partnered with STZ to launch cannabis-infused beverages. The drinks are expected to go on sale in Canada later in the year, which should nicely boost CGC's growth and propel CGC stovk price higher. * After the Farm Bill was signed into law, cannabidiol (CBD) products can be made in the U.S.. To this end, CGC has been building a sophisticated hemp-processing facility in New York. * CGC has agreed to acquire Acreage Holdings (OTCMKTS:ACRGF), which has cannabis licenses in 20 states and owns a retail chain called The Botanist. The deal will position the company to benefit from the anticipated legalization of cannabis in the U.S.on a federal level.The cannabis market will continue to be volatile. CGC is not the only operator with growing pains. Other marijuana companies, including Aphria (NYSE:APHA), Tilray (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) have also had problems. The Bottom Line on CGC StockLinton is a pioneer in the cannabis space and has quickly built an empire. As he was quoted as saying in last week's press release: "Creating Canopy Growth began with an abandoned chocolate factory and a vision."But those who have the talent to build an innovative company in an emerging market may not be the right people to run a large organization. Linton appears to be in the latter category.Yet the silver lining is that STZ recognized this early on and was not afraid to make a bold, somewhat risky, change. That is actually a bullish sign for CGC stock and should ultimately propel CGC stock price higher.Tom Taulli is the author of the upcoming book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Should Be Every Young Investor's First Choice * 5 IPO Stocks to Buy -- According to Wall Street Analysts * The Top 10 Best Sectors in the Market for 2019 The post Where Is Canopy Growth Stock Headed After the Shocking Removal of Its Co-CEO? appeared first on InvestorPlace.

  • PR Newswire7 days ago

    Aphria Inc. launches Plant Positivity social impact platform

    LEAMINGTON, ON, July 8, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced the launch of its new social impact platform, Plant Positivity. Championing the incredible power that plants have in overall well-being and providing greater access to green spaces for communities, Plant Positivity will be a new component of Aphria's existing Corporate Social Responsibility strategy, which will continue to deliver on the Company's commitment to give back to both people and the planet.

  • These 25 Pot Stocks Lost at Least 20% in the Second Quarter
    Motley Fool10 days ago

    These 25 Pot Stocks Lost at Least 20% in the Second Quarter

    A broad-based sell-off in marijuana stocks last quarter spared few cannabis investors.

  • Aphria Stock Could Become Cheap Soon
    InvestorPlace12 days ago

    Aphria Stock Could Become Cheap Soon

    Aphria (NYSE:APHA) stock hasn't moved much over the last two months. As Aphria stock works to recover from last year's implosion, analysts' estimates for APHA are falling even though it landed a lucrative vaping deal. Although Aphria Inc still has not fully regained the confidence of investors, strong production numbers and a move into vapes and concentrates could help send Aphria stock higher. APHA Is Still Recovering From Its 2018 DeclineAphria stock continues to suffer the impact of last year's swoon by APHA. The equity lost more than 75% of its value over three months last year as a short seller called Aphria Inc. a "shell game with a cannabis business on the side." Many expressed doubts about the company's Latin American acquisition, questioning the value of what it had obtained in the deal. This led to the departure of APHA's founder and then-CEO, Vic Neufeld. Irwin Simon, the founder and former CEO of Hain Celestial (NASDAQ:HAIN), took over on an interim basis. * 10 Stocks That Should Be Every Young Investor's First Choice The effects of last year's decline of Aphria stock linger. At around $7 per share, Aphria stock still trades almost 60% below its $16.86 per share high of last September. Also, unlike stocks such as Canopy Growth (NYSE:CGC), APHA stock did not regain its pre-Canada-legalization highs.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aphria Stock Will Benefit From Higher Production Levels, VapesThe collapse of APHA stock occurred despite the fact that Aphria Inc. became the third-largest cannabis producer in Canada, lagging only Aurora Cannabis (NYSE:ACB) and Canopy. Moreover, as dried cannabis falls in value, Aphria has partnered with Pax Labs to enable APHA's cannabis to be used in Pax's vaporizers. As InvestorPlace columnist Will Ashworth mentioned, vapes and concentrates help to diversify the company away from dried cannabis, whose prices continue to drop.Vaping is mostly positive for Aphria stock. Although Pax will also work with Aurora, Organigram (NASDAQ:OGI), and Supreme Cannabis (OTCMKTS:SPRWF), some estimate that vapes and concentrates will take up to 30% of the recreational market by 2021. Moreover, since Aphria is the second-largest cannabis producer in this group, Aphria's cannabis will be compatible with a significant percentage of Pax's devices. Aphria Stock Held Back by UncertaintyHowever, I think two factors will hold back Aphria stock. First, analysts' profit estimates for the company have fallen substantially over the last month. Three months ago, analysts forecast earnings per share of 38 Canadian cents Today, Wall Street analysts, on average, predict a loss of three Canadian cents per share.One research firm, Canaccord Genuity, cut its price target on Aphria stock to C$16 from C$18 per share and also reduced its revenue and earnings estimates. It cited slower-than-expected capacity growth as the reason for the cuts.The second concern involves leadership. The fact that Simon made the Pax deal despite his interim status highlights his ability. However, the company's leadership situation remains uncertain. That uncertainty likely exacerbated the decline of Aphria last year.But the price-sales ratio of Aphria stock is about 19\. That compares well to the price-sales ratios of Canopy and Aurora, which are 80.8 and 61.8, respectively. Many believe questions about Aphria's interim leadership have led to this lower multiple. Perhaps if the company could install a more permanent leadership team and somehow prevent earnings estimates for it from falling further, Aphria stock would reach its 52-week high or even move beyond that level. Final Thoughts on Aphria StockGiven APHA's valuation and potential market share, Aphria stock should eventually overcome its challenges. Despite its new (interim) CEO, APHA is still 50% below its 52-week high. Though Simon landed the vaping deal, he remains interim CEO, creating questions about the future direction of the company. Moreover, revenue and profit estimates continue to fall as sales across the industry disappoint.However, Aphria stock trades at a substantial discount to its larger peers, even as analysts' revenue and profit estimates for APHA fall. That could turn around as traders begin to see sales numbers rise from the company's sale of vapes, concentrates, and other products. Moreover, if APHA picks a permanent CEO, APHA could easily go from cheap for a reason to merely cheap.As of this writing, Will Healy is long APHA stock. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Should Be Every Young Investor's First Choice * 5 IPO Stocks to Buy -- According to Wall Street Analysts * The Top 10 Best Sectors in the Market for 2019 The post Aphria Stock Could Become Cheap Soon appeared first on InvestorPlace.

  • CNW Group12 days ago

    High Tide Announces Canna Cabana Now Selling Cannabis in Grande Prairie with 10 More Alberta Stores to Follow Shortly

    High Tide Announces Canna Cabana Now Selling Cannabis in Grande Prairie with 10 More Alberta Stores to Follow Shortly

  • Can Vaping Growth Help Investors Extract More Value From Aphria Stock?
    InvestorPlace14 days ago

    Can Vaping Growth Help Investors Extract More Value From Aphria Stock?

    Of the multiple positive catalysts should fuel Aphria Inc (NYSE:APHA) in the months ahead, the most intriguing one is is vaping, or using a vaporizer to get the desired effect from cannabis use. My InvestorPlace colleague Will Healy pointed out some of these catalysts in his June 6 article, when APHA stock was trading at more than 50% below its 52-week high.Source: Shutterstock InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe next day, Aphria announced that it had entered into a supply agreement for the Canadian market with San Francisco-based Pax Labs, a leader in the manufacture and sale of vaporizers. In the U.S. alone, Pax has sold more than 500,000 Era vaporizers to date with plenty of growth expected in the months and years ahead. "As Aphria continues to drive the evolution of the industry, we are thrilled to partner with a technology leader like PAX to provide a new avenue for consumers to integrate cannabis into their lives," said Irwin Simon, interim CEO of Aphria. "We are excited to bring our premium cannabis extracts from Solei, RIFF and our flagship medical cannabis brand, Aphria, to the PAX Era device and platform." Vaping is Going to Be Big in CanadaThe vaping market in Canada is expected to be significant. Aphria estimates that vapes and concentrates will account for up to 30% of the entire adult-use market by 2021. The great thing about vaping, from Aphria's perspective, is that concentrates provide a much higher margin than dried cannabis. * 7 Stocks to Buy for a Dovish Fed Statistics show that U.S. use of vape products is growing, while the use of dried flower is slowing. In Colorado, the use of vape products increased tremendously over three years. In 2014, vape products accounted for 12% of the legal market. By 2017, that number had grown to 23%. Meanwhile, over the same three years, the use of dried flower dropped by 12 percentage points to 54% of the market. Between edibles, concentrates, and infused drinks, the cannabis industry is moving away from the dried flower to an industry filled with choice. The fact that Aphria is partnering with one of the premier vape companies is a sign that Simon understands the importance of moving beyond supplying dried buds. APHA Is Not AloneThat only downside from Aphria's announcement is that PAX pick three other Canadian cannabis producers to help sell its product: Aurora Cannabis (NYSE:ACB), OrganiGram (NASDAQ:OGI), and Supreme Cannabis (OTCMKTS:SPRWF). However, the fact that Aphria is near completion of it $55 million Extraction Centre of Excellence in Leamington, Ontario, makes this concern far less of an issue. That's because when completed, Aphria will have annual extraction capacity of 200,240 kilograms, making it one of the largest extractors in Canada. Currently, analysts haven't factored Aphria's extraction facility into their valuation models. Once the facility is running, and products are available for sale in late December or early in 2020, Aphria stock is going to be far more attractive to investors than it is today. Bottom Line on Aphria StockIn May, I highlighted the pros and cons of the regime change at Aphria. As I stated, it's hard to know if Irwin Simon's the right person for the job. While his work at Hain Celestial (NASDAQ:HAIN) was at times exceptional, in recent years he did little to impress investors, eventually stepping down as CEO in June 2018. * The Top 8 Tech Stocks of 2019 (So Far) Joining the Aphria Inc board in December as chairman, Simon was appointed interim CEO on March 1 after former boss Vic Neufeld retired in January. Since then, Simon's made a few management changes to put his own stamp on the company. The PAX announcement is a sign Simon might be sticking around as the permanent CEO. If the board didn't have confidence in him, this kind of deal probably wouldn't have happened. While not completely sold on Simon, the PAX deal in combination with the completion of the extraction plant, suggests investors aren't giving Aphria stock its due.Aggressive investors ought to consider buying this potential growth and value play. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Top Small-Cap Stocks Of 2019 * Critical Levels to Watch in 7 Marijuana Stocks * 5 Smaller Cloud Stocks That Have Plenty of Potential Compare Brokers The post Can Vaping Growth Help Investors Extract More Value From Aphria Stock? appeared first on InvestorPlace.

  • The 10 Fastest-Growing Pot Stocks in 2020
    Motley Fool15 days ago

    The 10 Fastest-Growing Pot Stocks in 2020

    These cannabis stocks should see sales growth of at least 161% next year.

  • CNW Group18 days ago

    High Tide Reports Financial Results for Second Quarter 2019 Featuring a 325% Increase in Revenue over the Same Period of the Previous Year

    High Tide Reports Financial Results for Second Quarter 2019 Featuring a 325% Increase in Revenue over the Same Period of the Previous Year

  • Aphria Inc. (APHA) Gains As Market Dips: What You Should Know
    Zacks19 days ago

    Aphria Inc. (APHA) Gains As Market Dips: What You Should Know

    In the latest trading session, Aphria Inc. (APHA) closed at $6.98, marking a +0.87% move from the previous day.

  • Money flows in 17 popular marijuana stocks show fewer ‘short squeezes’
    MarketWatch19 days ago

    Money flows in 17 popular marijuana stocks show fewer ‘short squeezes’

    Prior low-level convictions for marijuana possession will be pardoned. Amid this news, one would expect marijuana stocks to run higher, but that’s not happening. Just like a doctor does X-rays to see what is going on inside the human body, investors can do an X-ray of marijuana stocks to figure out what is really going on.

  • 3 Popular Marijuana Stocks With Surprisingly Poor Margins
    Motley Fool19 days ago

    3 Popular Marijuana Stocks With Surprisingly Poor Margins

    These pot stocks leave a lot to be desired, fundamentally speaking.

  • CNW Group19 days ago

    High Tide Upgrades Grasscity to Magento 2 E-Commerce Platform

    As part of upgrading to the M2 platform the Company also improved Grasscity's warehouse management system, which is designed to reduce processing times and error rates, thereby increase shipments for faster delivery times to customers around the world. "We are excited to reap the benefits of this significant investment in Grasscity as the most searchable online retailer of smoking accessories.

  • The Surprising Pot Stock Forecast to Lead the Industry in 2020 Sales
    Motley Fool20 days ago

    The Surprising Pot Stock Forecast to Lead the Industry in 2020 Sales

    Hint: It's not Canopy Growth or Aurora Cannabis.

  • Are These Marijuana Stocks A Good Buy Now? Look Past The Hype
    Investor's Business Daily21 days ago

    Are These Marijuana Stocks A Good Buy Now? Look Past The Hype

    Are marijuana stocks on U.S. exchanges a good buy now? The marijuana industry gets a lot of hype, but look past the smoke and analyze pot stocks on their fundamentals and technicals.

  • Better Buy: Aphria vs. Canopy Growth
    Motley Fool22 days ago

    Better Buy: Aphria vs. Canopy Growth

    Which stock wins in a one-on-one matchup between two top Canadian cannabis producers?

  • 5 Most Popular Marijuana Stocks on the Market Right Now
    Motley Fool22 days ago

    5 Most Popular Marijuana Stocks on the Market Right Now

    Investors are voting with their pocketbooks on these popular pot stocks.

  • These Billion-Dollar Pot Stocks Are Buyout Candidates
    Motley Fool24 days ago

    These Billion-Dollar Pot Stocks Are Buyout Candidates

    Three marijuana stocks worth more than $1 billion that look more like acquisition targets than acquirers.